It is a pharma public limited company based in Vadodara, Gujarat, India, established in 1984.
1984 | Vadodara, Gujarat, India | AmalgamatedRanbaxy Drugs Limited, a amalgamated public limited company, was established on 31 January 1984 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232GJ1984PLC095288. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹100.05 Cr and a paid-up capital of ₹3.10 Cr.
Its leadership includes Meetal Sharad Sampat (Director), Sanjay Jerry (Director), Sandeep Mehandroo (Director). Past directors included Yogesh Kumar Sareen, Meetal Sharad Sampat, Arun Sawhney. Its latest AGM occurred on 07 August 2017, with the balance sheet filed on 31 March 2017. It is based at Sparc Tandalja, Vadodara, Gujarat, 390020.
U24232GJ1984PLC095288
095288
31 January 1984
₹100.05 Cr
₹3.10 Cr
Roc Ahmedabad
Unlisted
Amalgamated
Explore comprehensive insights into Ranbaxy Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meetal Sharad Sampat | Director | 31 Aug 2015 | Current |
| Sanjay Jerry | Director | 07 Mar 2014 | Current |
| Sandeep Mehandroo | Director | 04 Apr 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Feb 2008 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 24 Jun 2010 | Past |
| Pramod Abcsdd | Additional Director | 31 Aug 2015 | Past |
| Pramod Abcsdd | Key Managerial Personnel | - | Past |
| Pramod Abcsdd | Director | 03 Mar 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ranbaxy Drugs Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Ranbaxy Drugs had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ranbaxy Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ranbaxy Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ranbaxy Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ranbaxy Drugs Limited last Annual general meeting of members was held on 07 Aug 2017 as per latest MCA records. was documented.
Ranbaxy Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Ahmedabad. was recorded as a recent event.
Meetal Sharad Sampat was appointed as a Director was appointed as a Director on 31 Aug 2015 & has been associated with this company since 10 years 3 months . was recorded as a recent event.
Sanjay Jerry was appointed as a Director was appointed as a Director on 07 Mar 2014 & has been associated with this company since 11 years 8 months . was recorded as a recent event.
The activity Sandeep Mehandroo was appointed as a Director was appointed as a Director on 04 Apr 2008 & has been associated with this company since 17 years 7 months . was completed.
The activity Ranbaxy Drugs Limited was registered on 31 Jan 1984 with Roc Ahmedabad & aged 41 years 10 months as per MCA records. was completed.
The CIN of Ranbaxy Drugs Limited is U24232GJ1984PLC095288.
Ranbaxy Drugs Limited is headquartered at Sparc Tandalja, Vadodara, Gujarat, 390020.
Ranbaxy Drugs Limited was incorporated on 31 January 1984.
The current directors of Ranbaxy Drugs Limited are
The primary industry of Ranbaxy Drugs Limited is Pharma.
Ranbaxy Drugs Limited is unlisted.
The authorized capital of Ranbaxy Drugs Limited is ₹100.05 Cr, and the paid-up capital is ₹3.10 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX